Empagliflozin prevention of heart failure development in diabetes is associated with an improvement in cardiac energy producition
26 August 2018 (10:05 - 10:55)
Organised by:
Abstract
Slides
About the speaker

St. Michael's Hospital, Toronto (Canada)
6 More presentations in this session
Doctor H. Yip (Kaohsiung, TW)
Access the full session
The Event
ESC Congress 2018
26 August 2018
10:05 CET
You may be interested in
Congress Presentation
3 September 2019

Congress Presentation
28 August 2023

Congress Session
17 May 2025

Congress Session

